Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript

Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 5, 2026

Fortrea Reports First Quarter 2026 Results

Strong first-quarter performance reinforces confidence in FY 2026 guidance Book-to-bill of 1.15x is third consecutive quarter above 1.1x

GlobeNewsWire • May 5, 2026

Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates

Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.02 per share a year ago.

Zacks Investment Research • May 5, 2026

Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth

Fortrea Holdings Inc. (FTRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Apr 28, 2026

Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call

DURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results.

GlobeNewsWire • Apr 21, 2026

Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials

Highlights: Designed to transform clinical trial operations for sponsors, sites and study teams Persona driven, AI-powered solutions automate workflows and streamline oversight to help improve trial speed, predictability and quality Builds on Fortrea's flagship platform Xcellerate® to deliver near-real-time, role-based insights DURHAM, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global clinical research organization (CRO), today unveiled Fortrea Intelligent Technology™(FIT), a suite of innovative technology solutions designed to transform clinical trial operations.

GlobeNewsWire • Apr 7, 2026

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., March 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on March 10, 2026, to four newly hired employees. The award consisted of 130,000 RSUs that vest in three equal annual installments starting March 10, 2027, subject to the employee's continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company's Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an inducement material to the individual becoming a new employee of the Company.

GlobeNewsWire • Mar 10, 2026

Fortrea Holdings Inc. (FTRE) Q4 2025 Earnings Call Transcript

Fortrea Holdings Inc. (FTRE) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 26, 2026

Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Revenue and Adjusted EBITDA results delivered in line with stated full-year targets Full‑year cost savings exceeded previously communicated targets

GlobeNewsWire • Feb 26, 2026

Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates

Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.18 per share a year ago.

Zacks Investment Research • Feb 26, 2026